23 Mar Evaluating the Efficacy and Risks of Early Lecanemab Treatment in APOE4 Humanized Alzheimer’s Disease Mouse Models Posted at 13:05h in Other by Aania Rafi 0 Likes Share The page you are trying to access requires a login. If you have already registered for the Touchscreen Cognition community, please sign-in below. Or, please register to request access to this page. The Touchscreen Cognition Team Username or E-mail Password * Remember Me Forgot Password
